A Phase 3, Placebo-Controlled, Randomized, Observer-Blinded Study to Evaluate The Efficacy, Safety, and Tolerability of A Clostridium Difficile Vaccine In Adults 50 Years Of Age and Older

  • STATUS
    None
  • sponsor
    Pfizer
Updated on 7 November 2020

Summary

A Phase 3, Placebo-Controlled, Randomized, Observer-Blinded Study to Evaluate The Efficacy, Safety, and Tolerability of A Clostridium Difficile Vaccine In Adults 50 Years Of Age and Older

Description

We are conducting a study to find out if an investigational vaccine prevents severe diarrhea caused by a germ (bacterium) called Clostridium difficile (C diff) in subjects 50 year of age and older

.

Details
Clinical Study IdentifierTX11887
SponsorPfizer
Last Modified on7 November 2020

Adding a note
adding personal notes guide

Select a piece of text and start making personal notes.

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

Study

user name

Annotated by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No made yet